CoreAge Rx vs RX Bella
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and RX Bella head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 63 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make RX Bella a bad call — it's best for readers who can verify the selected prescription and resolve conflicting membership, refill and initial-order cancellation deadlines. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | RX Bella |
|---|---|---|
| Brief Score | 94/100 (A) | 63/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Homepage from $249/month Current compounded-injection card includes visit, prescription, delivery and ongoing care. Generic $199/month headline differs; confirm selected dose, supply and full commitment. Thirty-day notice in product FAQ differs from forty-eight-hour auto-refill rule in terms. Initial order cancellation has a separate twenty-four-hour/provider-receipt limit. Full price detailsCompounded semaglutide injection offered; complete selected-plan quote unknown; current homepage medication card starts at $249/month with visit, prescription, delivery and ongoing care; separate generic program headline starts at $199/month |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Homepage from $299/month Current compounded-injection card includes visit, prescription, delivery and ongoing care. Generic $199/month headline differs; confirm selected dose, supply and full commitment. Confirm governing refund conditions. Damage/wrong-item requests need contact within forty-eight hours; returned prescriptions may incur a $35 disposal fee. Full price detailsCompounded tirzepatide injection offered; complete selected-plan quote unknown; current homepage medication card starts at $299/month with visit, prescription, delivery and ongoing care; separate generic program headline starts at $199/month |
| Coverage | US only; restrictions by state, confirmed at intake | Nationwide telehealth advertised; actual service depends on provider licensing, patient location and state-specific rules |
| Brand-name access | Not confirmed | Current reviewed compounded programs do not establish a named branded GLP-1 prescribing service. |
| Oral / sublingual | Injection only | Unconfirmed |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
RX Bella: Homepage medication cards start at $249/month semaglutide and $299/month tirzepatide, alongside a generic $199 headline. Resolve thirty-day FAQ versus forty-eight-hour refill terms and the initial twenty-four-hour/provider-receipt cutoff.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.